Genomic aberrations and cellular heterogeneity in SV40-immortalized human corneal epithelial cells

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 2, 2009, Pages 604-613

  Yamasaki, Kenta ^a   Kawasaki, Satoshi ^a   Young, Robert D ^b   Fukuoka, Hideki ^a   Tanioka, Hidetoshi ^a   Nakatsukasa, Mina ^a   Quantock, Andrew J ^b   Kinoshita, Shigeru ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS LARGE T ANTIGEN; VIRUS T ANTIGEN;

ARTICLE; CELL GROWTH; CELL HETEROGENEITY; CELL KINETICS; CELL POPULATION; CELL STRUCTURE; CHROMOSOME 9P; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CORNEA CELL; CORNEA EPITHELIUM; ELECTRIC RESISTANCE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSFECTION; GENOMICS; HUMAN; HUMAN CELL; IN VITRO STUDY; INVERSE POLYMERASE CHAIN REACTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIMIAN VIRUS 40; SOUTHERN BLOTTING; T LYMPHOCYTE; CELL LINE; CYTOLOGY; DNA MICROARRAY; GENETIC TRANSCRIPTION; GENETICS; IMPEDANCE; METABOLISM; NUCLEIC ACID HYBRIDIZATION; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; VIROLOGY; VIRUS CELL TRANSFORMATION;

ANTIGENS, POLYOMAVIRUS TRANSFORMING; BLOTTING, SOUTHERN; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; CHROMOSOME ABERRATIONS; ELECTRIC IMPEDANCE; EPITHELIUM, CORNEAL; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MICROSCOPY, ELECTRON, SCANNING; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIMIAN VIRUS 40; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 59449091421     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2239     Document Type: Article

References (54)

1. Araki-Sasaki K, Ohashi Y, Sasabe T, et al. An SV40-immortalized human corneal epithelial cell line and its characterization. Invest Ophthalmol Vis Sci. 1995;36:614-621.
2. Kahn CR, Young E, Lee IH, Rhim JS. Human corneal epithelial primary cultures and cell lines with extended life span: in vitro model for ocular studies. Invest Ophthalmol Vis Sci. 1993;34:3429-3441.
3. Offord EA, Sharif NA, Mace K, et al. Immortalized human corneal epithelial cells for ocular toxicity and inflammation studies. Invest Ophthalmol Vis Sci. 1999;40:1091-1101.
4. Griffith M, Osborne R, Munger R, et al. Functional human corneal equivalents constructed from cell lines. Science. 1999;286:2169-2172.
5. Rheinwald JG, Hahn WC, Ramsey MR, et al. A two-stage, p16(INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status. Mol Cell Biol. 2002;22:5157-5172.
6. Mohan RR, Possin DE, Sinha S, Wilson SE. Development of genetically engineered tet HPV16-E6/E7 transduced human corneal epithelial clones having tight regulation of proliferation and normal differentiation. Exp Eye Res. 2003;77:395-407.
7. Robertson DM, Li L, Fisher S, et al. Characterization of growth and differentiation in a telomerase-immortalized human corneal epithelial cell line. Invest Ophthalmol Vis Sci. 2005;46:470-478.
8. Saarinen-Savolainen P, Jarvinen T, Araki-Sasaki K, Watanabe H, Urtti A. Evaluation of cytotoxicity of various ophthalmic drugs, eye drop excipients and cyclodextrins in an immortalized human corneal epithelial cell line. Pharm Res. 1998;15:1275-1280.
9. Papa V, Leonardi A, Getuli C, et al. Effect of ofloxacin and netilmicin on human corneal and conjunctival cells in vitro. J Ocul Pharmacol Ther. 2003;19:535-545.
10. Kimura K, Teranishi S, Yamauchi J, Nishida T. Role of JNK-dependent serine phosphorylation of paxillin in migration of corneal epithelial cells during wound closure. Invest Ophthalmol Vis Sci. 2008;49:125-132.
11. Yin J, Xu K, Zhang J, Kumar A, Yu FS. Wound-induced ATP release and EGF receptor activation in epithelial cells. J Cell Sci. 2007;120:815-825.
12. Van Doren K, Gluzman Y. Efficient transformation of human fibroblasts by adenovirus-simian virus 40 recombinants. Mol Cell Biol. 1984;4:1653-1656.
13. Lane DP, Simanis V, Bartsch R, et al. Cellular targets for SV40 large T-antigen. Proc R Soc Lond B Biol Sci. 1985;226:25-42.
14. Cobrinik D. Pocket proteins and cell cycle control. Oncogene. 2005;24:2796-2809.
15. Shay JW, Wright WE, Werbin H. Defining the molecular mechanisms of human cell immortalization. Biochim Biophys Acta. 1991;1072:1-7.
16. Goodrich DW. The retinoblastoma tumor-suppressor gene, the exception that proves the rule. Oncogene. 2006;25:5233-5243.
17. Callegari AJ, Kelly TJ. Shedding light on the DNA damage checkpoint. Cell Cycle. 2007;6:660-666.
18. Harrington EA, Bruce JL, Harlow E, Dyson N. pRB plays an essential role in cell cycle arrest induced by DNA damage. Proc Natl Acad Sci U S A 1998;95:11945-11950.
19. Rodier F, Campisi J, Bhaumik D. Two faces of p53: aging and tumor suppression. Nucleic Acids Res. 2007;35:7475-7484.
20. Hollstein M, Moeckel G, Hergenhahn M, et al. On the origins of tumor mutations in cancer genes: insights from the p53 gene. Mutat Res. 1998;405:145-154.
21. Tchinda J, Volpert S, McNeil N, et al. Multicolor karyotyping in acute myeloid leukemia. Leuk Lymphoma. 2003;44:1843-1853.
22. Myllykangas S, Himberg J, Bohling T, et al. DNA copy number amplification profiling of human neoplasms. Oncogene. 2006;25:7324-7332.
23. Stewart N, Bacchetti S. Expression of SV40 large T antigen, but not small t antigen, is required for the induction of chromosomal aberrations in transformed human cells. Virology. 1991;180:49-57.
24. Ray FA, Peabody DS, Cooper JL, Cram LS, Kraemer PM. SV40 T antigen alone drives karyotype instability that precedes neoplastic transformation of human diploid fibroblasts. J Cell Biochem. 1990;42:13-31.
25. Ebato B, Friend J, Thoft RA. Comparison of central and peripheral human corneal epithelium in tissue culture. Invest Ophthalmol Vis Sci. 1987;28:1450-1456.
26. Okubo K, Hori N, Matoba R, et al. Large scale cDNA sequencing for analysis of quantitative and qualitative aspects of gene expression. Nat Genet. 1992;2:173-179.
27. Futreal PA, Coin L, Marshall M, et al. A census of human cancer genes. Nat Rev Cancer. 2004;4:177-183.
28. Sawinska M, Schmitt JG, Sagulenko E, et al. Novel aphidicolininducible common fragile site FRA9G maps to 9p22.2, within the C9orf39 gene. Genes Chromosomes Cancer. 2007;46:991-999.
29. Mishmar D, Rahat A, Scherer SW, et al. Molecular characterization of a common fragile site (FRA7H) on human chromosome 7 by the cloning of a simian virus 40 integration site. Proc Natl Acad Sci U S A 1998;95:8141-8146.
30. Bowden PE, Hainey SD, Parker G, et al. Characterization and chromosomal localization of human hair-specific keratin genes and comparative expression during the hair growth cycle. J Invest Dermatol. 1998;110:158-164.
31. Kawamoto S, Yoshii J, Mizuno K, et al. BodyMap: a collection of 3′ ESTs for analysis of human gene expression information. Genome Res. 2000;10:1817-1827.
32. Hishiki T, Kawamoto S, Morishita S, Okubo K. BodyMap: a human and mouse gene expression database. Nucleic Acids Res. 2000;28:136-138.
33. Nishida K, Adachi W, Shimizu-Matsumoto A, et al. A gene expression profile of human corneal epithelium and the isolation of human keratin 12 cDNA. Invest Ophthalmol Vis Sci. 1996;37:1800-1809.
34. Kurpakus MA, Stock EL, Jones JC. Expression of the 55-kD/64-kD corneal keratins in ocular surface epithelium. Invest Ophthalmol Vis Sci. 1990;31:448-456.
35. Abedinia M, Pain T, Algar EM, Holmes RS. Bovine corneal aldehyde dehydrogenase: the major soluble corneal protein with a possible dual protective role for the eye. Exp Eye Res. 1990;51:419-426.
36. Su M, Chin SF, Li XY, et al. Comparative genomic hybridization of esophageal adenocarcinoma and squamous cell carcinoma cell lines. Dis Esophagus. 2006;19:10 -14.
37. Wang LD, Qin YR, Fan ZM, et al. Comparative genomic hybridization: comparison between esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high-incidence area for both cancers in Henan, northern China. Dis Esophagus. 2006;19:459-467.
38. Rao PH, Arias-Pulido H, Lu XY, et al. Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma. BMC Cancer. 2004;4:5.
39. Huang FY, Kwok YK, Lau ET, et al. Genetic abnormalities and HPV status in cervical and vulvar squamous cell carcinomas. Cancer Genet Cytogenet. 2005;157:42-48.
40. Choi YW, Bae SM, Kim YW, et al. Gene expression profiles in squamous cell cervical carcinoma using array-based comparative genomic hybridization analysis. Int J Gynecol Cancer. 2007;17:687-696.
41. Nesbit CE, Tersak JM, Prochownik EV. MYC oncogenes and human neoplastic disease. Oncogene. 1999;18:3004-3016.
42. Schmidt EV. The role of c-myc in cellular growth control. Oncogene. 1999;18:2988-2996.
43. Wu KJ, Grandori C, Amacker M, et al. Direct activation of TERT transcription by c-MYC. Nat Genet. 1999;21:220-224.
44. Ito H, Kyo S, Kanaya T, et al. Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer. Clin Cancer Res. 1998;4:1603-1608.
45. Kanaya T, Kyo S, Takakura M, et al. hTERT is a critical determinant of telomerase activity in renal-cell carcinoma. Int J Cancer. 1998;78:539-543.
46. Takakura M, Kyo S, Kanaya T, Tanaka M, Inoue M. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res. 1998;58:1558-1561.
47. Counter CM, Hirte HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci U S A. 1994;91:2900-2904.
48. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011-2015.
49. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer. 1997;33:787-791.
50. Nakayama J, Tahara H, Tahara E, et al. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet. 1998;18:65-68.
51. Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science. 1998;279:349-352.
52. Nigro JM, Baker SJ, Preisinger AC, et al. Mutations in the p53 gene occur in diverse human tumour types. Nature. 1989;342:705-708.
53. Soussi T. p53 Antibodies in the sera of patients with various types of cancer: a review. Cancer Res. 2000;60:1777-1788.
54. Sugimoto T, Arai M, Shimada H, Hata A, Seki N. Integrated analysis of expression and genome alteration reveals putative amplified target genes in esophageal cancer. Oncol Rep. 2007;18:465-472.